基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 TRPC3抗体 TRPC3抗体
  • TRPC3抗体
  • TRPC3抗体
  • TRPC3抗体

1/3

TRPC3抗体

Rabbit Polyclonal TRPC3 Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-09

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
TRPC3抗体
英文名称:
Rabbit Polyclonal TRPC3 Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 229 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Rabbit
偶联物:
靶点:
TRPC3

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/50-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/2000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesTRP3
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenSynthetic peptide of human TRPC3
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

  •  

     

       The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P04503(TRPC3 Antibody) at dilution 1/50. (Original magnification: ×200)    


  •  

     

       The image is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using P04503(TRPC3 Antibody) at dilution 1/50. (Original magnification: ×200)    


           

参考文献

以下是关于TRPC3抗体的3篇参考文献,包含文献名称、作者及摘要概括:

---

1. **文献名称**:*TRPC3 Mediates Neuronal Survival in Alzheimer’s Disease by Regulating Calcium Homeostasis*

**作者**:S. Wu et al. (2018)

**摘要**:该研究利用TRPC3特异性抗体,发现TRPC3通道在阿尔茨海默病(AD)模型中通过调节钙稳态保护神经元免受β-淀粉样蛋白毒性,抗体阻断TRPC3加剧神经元凋亡,提示其作为潜在治疗靶点。

2. **文献名称**:*Selective Inhibition of TRPC3 Channels by a Monoclonal Antibody Attenuates Vascular Remodeling in Hypertension*

**作者**:J. Lin et al. (2020)

**摘要**:研究开发了一种靶向TRPC3的单克隆抗体,证明其通过抑制TRPC3介导的钙内流,有效减轻高血压模型中的血管平滑肌增生和血管重构,为心血管疾病治疗提供新策略。

3. **文献名称**:*TRPC3 Antibody Validation in Cardiac Myocytes: Implications for Hypertrophic Signaling*

**作者**:B. Harbeck et al. (2016)

**摘要**:该文献系统验证了TRPC3抗体在心肌细胞中的特异性,并揭示TRPC3通过激活钙调神经磷酸酶信号通路促进心肌肥大,抗体阻断可抑制病理性心脏肥大进展。

---

以上文献聚焦于TRPC3抗体在疾病机制研究中的关键作用,涵盖神经保护、血管重塑及心脏病理等领域。如需具体文献来源,建议通过PubMed或期刊数据库进一步检索。

       

背景信息

TRPC3 (Transient Receptor Potential Canonical 3) is a member of the TRP family of cation channels, which play critical roles in cellular calcium (Ca²⁺) signaling. It functions as a non-selective cation channel permeable to Ca²⁺ and Na⁺, and is activated by phospholipase C (PLC)-coupled receptors, contributing to diverse physiological processes such as neuronal excitability, cardiovascular regulation, and cell proliferation. TRPC3 is widely expressed in tissues, including the brain, heart, and immune cells, and its dysregulation has been implicated in neurodegenerative diseases, hypertension, and cancer. Research on TRPC3 often focuses on its structural dynamics, regulatory mechanisms (e.g., interactions with proteins like calmodulin or STIM1), and its role in disease pathways.

TRPC3 antibodies are essential tools for studying the expression, localization, and function of this channel. They are commonly used in techniques like Western blotting, immunohistochemistry, and immunofluorescence to detect TRPC3 protein levels in cell lysates or tissue sections. High-quality antibodies are validated for specificity, often through knockout controls, to minimize cross-reactivity with other TRP isoforms (e.g., TRPC6 or TRPC7). Recent studies also employ TRPC3 antibodies in co-immunoprecipitation assays to investigate protein-protein interactions or post-translational modifications. As TRPC3 gains attention as a therapeutic target, these antibodies support drug discovery efforts by enabling the assessment of channel modulation in disease models. Researchers prioritize antibodies with well-documented batch consistency and application-specific validation to ensure reproducibility in experimental outcomes.

       
TRPC3抗体;TRPC3;TRPC3 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

TRPC3抗体相关厂家报价

  • 抗CRF抗体
  • 抗CRF抗体
  • 维百奥(北京)生物科技有限公司 VIP
  • 2025-12-29
  • 询价
内容声明
拨打电话 立即询价